BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Update

BioNxt Solutions Inc. (OTCMKTS:BNXTF) saw a significant decrease in short interest in July. As of July 31st, there was short interest totaling 1,000 shares, a decrease of 99.2% from the July 15th total of 132,765 shares. Based on an average daily volume of 484 shares, the short-interest ratio is presently 2.1 days. Approximately 0.0% of the shares of the stock are sold short.

BioNxt Solutions Price Performance

BNXTF stock opened at $0.23 on Thursday. The company’s 50 day simple moving average is $0.24 and its 200-day simple moving average is $0.34. BioNxt Solutions has a 12 month low of $0.14 and a 12 month high of $0.80. The firm has a market capitalization of $31.08 million, a PE ratio of -4.57 and a beta of 0.70.

BioNxt Solutions (OTCMKTS:BNXTF) last issued its quarterly earnings data on Friday, May 29th. The company reported ($0.01) earnings per share (EPS) for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.

BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.